Pub Date : 2025-10-16eCollection Date: 2025-01-01DOI: 10.1055/a-2689-5839
Tonya Kaltenbach, Luke Martin, Jessica Yu, Benjamin Brooke, William Peche, Roy Soetikno, Mary Whooley, Andrew J Gawron
Background and study aims: Although endoscopic resection is recommended for management of complex benign colon polyps, patients are routinely referred for surgical resection. Little is known about the effects of these elective colectomies on patient outcomes. We sought to determine trends, surgical outcomes, and costs of elective colectomy for benign colon polyps.
Patients and methods: We performed a retrospective cohort analysis of veterans nationwide using the National Veterans Affairs Surgical Quality Improvement Program (VASQIP) database linked to the national VA Corporate Data Warehouse database. We included all veterans (N = 7,102) undergoing elective colectomy for benign polyps from 2000 to 2015. Outcomes of interest were rates of colectomy, surgical pathology findings, morbidity, mortality, and costs.
Results: Colectomy for benign polyps increased significantly from 6% of all colectomies in 2000 to 18% in 2014, and the percent of colectomies for colon cancer decreased from 40% to 31%. The 30-day mortality rate was 1.2% and the complication rate was 19.7%. Based on pathology, 80% of patients (n = 514) underwent right hemicolectomy, mean polyp size was 2.7 cm (± 1.7 cm), and 60.1% of resected polyps were adenomas. Median cost of colectomy was $22,712 for open and $20,697 for laparoscopic colectomy. Costs increased if a complication occurred.
Conclusions: Rates of colectomy for benign adenomas significantly increased from 2000 to 2014. Colectomy was associated with significant mortality, morbidity, and cost. Development of strategies to improve endoscopic management of benign large colon neoplasms is urgently needed.
{"title":"Elective colectomy for treatment of benign colon polyps: National surgical trends, outcomes, and cost analysis.","authors":"Tonya Kaltenbach, Luke Martin, Jessica Yu, Benjamin Brooke, William Peche, Roy Soetikno, Mary Whooley, Andrew J Gawron","doi":"10.1055/a-2689-5839","DOIUrl":"10.1055/a-2689-5839","url":null,"abstract":"<p><strong>Background and study aims: </strong>Although endoscopic resection is recommended for management of complex benign colon polyps, patients are routinely referred for surgical resection. Little is known about the effects of these elective colectomies on patient outcomes. We sought to determine trends, surgical outcomes, and costs of elective colectomy for benign colon polyps.</p><p><strong>Patients and methods: </strong>We performed a retrospective cohort analysis of veterans nationwide using the National Veterans Affairs Surgical Quality Improvement Program (VASQIP) database linked to the national VA Corporate Data Warehouse database. We included all veterans (N = 7,102) undergoing elective colectomy for benign polyps from 2000 to 2015. Outcomes of interest were rates of colectomy, surgical pathology findings, morbidity, mortality, and costs.</p><p><strong>Results: </strong>Colectomy for benign polyps increased significantly from 6% of all colectomies in 2000 to 18% in 2014, and the percent of colectomies for colon cancer decreased from 40% to 31%. The 30-day mortality rate was 1.2% and the complication rate was 19.7%. Based on pathology, 80% of patients (n = 514) underwent right hemicolectomy, mean polyp size was 2.7 cm (± 1.7 cm), and 60.1% of resected polyps were adenomas. Median cost of colectomy was $22,712 for open and $20,697 for laparoscopic colectomy. Costs increased if a complication occurred.</p><p><strong>Conclusions: </strong>Rates of colectomy for benign adenomas significantly increased from 2000 to 2014. Colectomy was associated with significant mortality, morbidity, and cost. Development of strategies to improve endoscopic management of benign large colon neoplasms is urgently needed.</p>","PeriodicalId":11671,"journal":{"name":"Endoscopy International Open","volume":"13 ","pages":"a26895839"},"PeriodicalIF":2.3,"publicationDate":"2025-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12550741/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145376384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-16eCollection Date: 2025-01-01DOI: 10.1055/a-2689-5949
Gianenrico Rizzatti, Bertrand Napoléon, Fabrice Caillol, Stefano Francesco Crinó, Germana de Nucci, Khanh Do-Cong Pham, Marc Giovannini, Sarah Leblanc, Silvia Della Torre, Laurent Palazzo, Pia Clara Pafundi, Maria Cristina Conti Bellocchi, Cristiano Spada, Alberto Larghi
Background and study aims: Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) has been proposed as a minimally invasive alternative to surgery for treatment of both functional (F-) and non-functional (NF-) pancreatic neuroendocrine tumors (PanNETs). We performed a large prospective multicenter study to evaluate safety and effectiveness of EUS-RFA in patients with F- and NF-PanNETs.
Patients and methods: Patients with F- (≤ 2 cm) and NF-PanNETs (15 mm-25 mm) were prospectively enrolled over a 43-month period. The primary aim was safety, defined as rate of adverse events (AEs). The secondary aim was effectiveness defined as complete disappearance of the hormonal secretion syndrome in F- PanNETs, whereas for NF-PanNETs, complete response was defined as absence of enhancing tissue and of detectable lesion at magnetic resonance imaging/computed tomography scan and Gallium-positron emission tomography, respectively. The EUSRA 19G needle was used in all patients. After treatment completion, follow-up was performed for 1 year.
Results: During the study period, a total of 60 patients were enrolled, 30 with insulinomas and 30 with NF-PanNETs (mean lesion size 14.5 ± 4.5 mm). In 78.3% of patients, a single RFA session was performed. Overall, AEs occurred in nine of 60 patients (15%), in four patients (13.3%) with insulinomas and in five (16.7%) with NF-PanNETs, with only one severe AE. Complete insulin hypersecretion symptom resolution was obtained in 29 of 30 patients (96.7%) with insulinomas, whereas for NF-PanNETs, complete radiological response was obtained in 22 of 25 patients (88%) with long-term follow up.
Conclusions: Our prospective international multicenter study demonstrated that EUS-RFA is highly safe and effective for the treatment for both F- and NF-PanNETs.
{"title":"Endoscopic ultrasound-guided radiofrequency ablation for treatment of pancreatic neuroendocrine tumors: Multicenter prospective study.","authors":"Gianenrico Rizzatti, Bertrand Napoléon, Fabrice Caillol, Stefano Francesco Crinó, Germana de Nucci, Khanh Do-Cong Pham, Marc Giovannini, Sarah Leblanc, Silvia Della Torre, Laurent Palazzo, Pia Clara Pafundi, Maria Cristina Conti Bellocchi, Cristiano Spada, Alberto Larghi","doi":"10.1055/a-2689-5949","DOIUrl":"10.1055/a-2689-5949","url":null,"abstract":"<p><strong>Background and study aims: </strong>Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) has been proposed as a minimally invasive alternative to surgery for treatment of both functional (F-) and non-functional (NF-) pancreatic neuroendocrine tumors (PanNETs). We performed a large prospective multicenter study to evaluate safety and effectiveness of EUS-RFA in patients with F- and NF-PanNETs.</p><p><strong>Patients and methods: </strong>Patients with F- (≤ 2 cm) and NF-PanNETs (15 mm-25 mm) were prospectively enrolled over a 43-month period. The primary aim was safety, defined as rate of adverse events (AEs). The secondary aim was effectiveness defined as complete disappearance of the hormonal secretion syndrome in F- PanNETs, whereas for NF-PanNETs, complete response was defined as absence of enhancing tissue and of detectable lesion at magnetic resonance imaging/computed tomography scan and Gallium-positron emission tomography, respectively. The EUSRA 19G needle was used in all patients. After treatment completion, follow-up was performed for 1 year.</p><p><strong>Results: </strong>During the study period, a total of 60 patients were enrolled, 30 with insulinomas and 30 with NF-PanNETs (mean lesion size 14.5 ± 4.5 mm). In 78.3% of patients, a single RFA session was performed. Overall, AEs occurred in nine of 60 patients (15%), in four patients (13.3%) with insulinomas and in five (16.7%) with NF-PanNETs, with only one severe AE. Complete insulin hypersecretion symptom resolution was obtained in 29 of 30 patients (96.7%) with insulinomas, whereas for NF-PanNETs, complete radiological response was obtained in 22 of 25 patients (88%) with long-term follow up.</p><p><strong>Conclusions: </strong>Our prospective international multicenter study demonstrated that EUS-RFA is highly safe and effective for the treatment for both F- and NF-PanNETs.</p>","PeriodicalId":11671,"journal":{"name":"Endoscopy International Open","volume":"13 ","pages":"a26895949"},"PeriodicalIF":2.3,"publicationDate":"2025-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12550746/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145376418","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-16eCollection Date: 2025-01-01DOI: 10.1055/a-2713-0016
Kambiz Kadkhodayan, Azhar Hussain, Abdullah Abassi, Saurabh Chandan, Sagar Pathak, Gustavo Bello Vincentelli, Natalie Cosgrove, Mustafa A Arain, Maham Hayat, Deepanshu Jain, Artur Viana, Mohamad Khaled Almujarkesh, Tareq Alsaleh, Magda Elamin, Nihal Ijaz Khan, Dennis Yang, Shayan Irani, Muhammad Khalid Hasan
Background and study aims: Roux-en-Y gastric bypass (RYGB) is an effective long-term weight loss operation with improvements in metabolic diseases. Nutritional deficiencies, however, are highly prevalent despite supplementation, largely due to exclusion of the proximal small bowel. In RYGB patients who require pancreaticobiliary access, the EUS-directed transgastric ERCP (EDGE) procedure provides a stable gastro-gastric (GG) fistula using a lumen-apposing metal stent (LAMS). The metabolic and nutritional effects of temporary food diversion remain unknown.
Methods: We conducted a review of 60 consecutive RYGB patients from two tertiary centers who underwent EDGE. Nutritional and metabolic parameters were assessed before LAMS placement and after removal.
Results: Mean age was 63.2 ± 11.05 years; 23% were male. Significant improvements were observed in serum hemoglobin (mean difference (MD) 1.1 g/dL; P = 0.004), vitamin B12 levels (MD 204.4 pg/mL; P = 0.021), iron (MD 57.9 mcg/dL; P = 0.017), albumin (MD 0.4 g/dL; P = 0.013), and magnesium levels (MD 0.24 mg/dL; P = 0.016). In addition, serum folate (MD 2.2 μg/mL; P = 0.873), and ferritin levels (MD 315.5 μg/mL; P = 0.335), showed improvement trends, but these did not reach statistical significance. No significant changes were observed in total body weight, body mass index, serum glucose, hemoglobin A1c, serum triglycerides, low-density lipoprotein, or high-density lipoprotein ( P > 0.05 for all).
Conclusions: Temporary partial-reversal of RYGB using a LAMS improves key nutritional parameters without compromising metabolic benefits of RYGB. These findings may support a therapeutic role for iatrogenic GG fistulas as a minimally invasive option for RYGB patients with refractory nutritional deficiencies.
背景与研究目的:Roux-en-Y胃旁路术(RYGB)是一种有效的长期减肥手术,可改善代谢性疾病。然而,尽管补充了营养,营养缺乏仍然非常普遍,这主要是由于排除了近端小肠。在需要胰胆通道的RYGB患者中,eus引导的经胃ERCP (EDGE)手术使用腔内金属支架(LAMS)提供稳定的胃-胃(GG)瘘。暂时食物转移的代谢和营养影响尚不清楚。方法:我们对来自两个三级中心的60例连续接受EDGE治疗的RYGB患者进行了回顾。在LAMS放置前和移除后评估营养和代谢参数。结果:平均年龄63.2±11.05岁;23%是男性。血清血红蛋白显著改善(平均差值(MD) 1.1 g/dL;P = 0.004)、维生素B12 (MD 204.4 pg/mL, P = 0.021)、铁(MD 57.9 mcg/dL, P = 0.017)、白蛋白(MD 0.4 g/dL, P = 0.013)和镁(MD 0.24 mg/dL, P = 0.016)。血清叶酸水平(MD 2.2 μg/mL, P = 0.873)、铁蛋白水平(MD 315.5 μg/mL, P = 0.335)均有改善趋势,但均无统计学意义。总体重、体重指数、血清葡萄糖、血红蛋白A1c、血清甘油三酯、低密度脂蛋白、高密度脂蛋白均无显著变化(P < 0.05)。结论:使用LAMS暂时部分逆转RYGB可改善关键营养参数,而不影响RYGB的代谢益处。这些发现可能支持医源性GG瘘作为难治性营养缺乏的RYGB患者的微创选择的治疗作用。
{"title":"Therapeutic potential of gastro-gastric fistulas created via lumen-apposing metal stents for nutritional deficiencies after roux-en-y gastric bypass.","authors":"Kambiz Kadkhodayan, Azhar Hussain, Abdullah Abassi, Saurabh Chandan, Sagar Pathak, Gustavo Bello Vincentelli, Natalie Cosgrove, Mustafa A Arain, Maham Hayat, Deepanshu Jain, Artur Viana, Mohamad Khaled Almujarkesh, Tareq Alsaleh, Magda Elamin, Nihal Ijaz Khan, Dennis Yang, Shayan Irani, Muhammad Khalid Hasan","doi":"10.1055/a-2713-0016","DOIUrl":"10.1055/a-2713-0016","url":null,"abstract":"<p><strong>Background and study aims: </strong>Roux-en-Y gastric bypass (RYGB) is an effective long-term weight loss operation with improvements in metabolic diseases. Nutritional deficiencies, however, are highly prevalent despite supplementation, largely due to exclusion of the proximal small bowel. In RYGB patients who require pancreaticobiliary access, the EUS-directed transgastric ERCP (EDGE) procedure provides a stable gastro-gastric (GG) fistula using a lumen-apposing metal stent (LAMS). The metabolic and nutritional effects of temporary food diversion remain unknown.</p><p><strong>Methods: </strong>We conducted a review of 60 consecutive RYGB patients from two tertiary centers who underwent EDGE. Nutritional and metabolic parameters were assessed before LAMS placement and after removal.</p><p><strong>Results: </strong>Mean age was 63.2 ± 11.05 years; 23% were male. Significant improvements were observed in serum hemoglobin (mean difference (MD) 1.1 g/dL; <i>P</i> = 0.004), vitamin B12 levels (MD 204.4 pg/mL; <i>P</i> = 0.021), iron (MD 57.9 mcg/dL; <i>P</i> = 0.017), albumin (MD 0.4 g/dL; <i>P</i> = 0.013), and magnesium levels (MD 0.24 mg/dL; <i>P</i> = 0.016). In addition, serum folate (MD 2.2 μg/mL; <i>P</i> = 0.873), and ferritin levels (MD 315.5 μg/mL; <i>P</i> = 0.335), showed improvement trends, but these did not reach statistical significance. No significant changes were observed in total body weight, body mass index, serum glucose, hemoglobin A1c, serum triglycerides, low-density lipoprotein, or high-density lipoprotein ( <i>P</i> > 0.05 for all).</p><p><strong>Conclusions: </strong>Temporary partial-reversal of RYGB using a LAMS improves key nutritional parameters without compromising metabolic benefits of RYGB. These findings may support a therapeutic role for iatrogenic GG fistulas as a minimally invasive option for RYGB patients with refractory nutritional deficiencies.</p>","PeriodicalId":11671,"journal":{"name":"Endoscopy International Open","volume":"13 ","pages":"a27130016"},"PeriodicalIF":2.3,"publicationDate":"2025-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12550740/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145376421","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-13eCollection Date: 2025-01-01DOI: 10.1055/a-2703-3219
Marc Harb, Jean Baptiste Danset, Cynthia Medlij, Olivier Marty, Damien Levoir, Elise Chanteloup, Bernard El Khoury, Christophe Souaid, Yann Le Baleur
Background and study aims: Multiple therapeutic modalities, including surgery and rigid and flexible endoscopy, have been adopted to manage Zenker's diverticulum (ZD). Relief from symptoms such as dysphagia and regurgitation is the main goal of therapy in symptomatic ZD. This study was the first large cohort that aimed to assess efficacy with time and safety of endoscopic diverticulotomy using the Clutch Cutter.
Patients and methods: Cricopharyngeal myotomy was performed in 43 patients at Hospital Saint Joseph de Paris, a tertiary referral center. Symptoms were analyzed before and at 3, 6, and 12 months post-intervention using an extensive questionnaire about dysphagia, odynophagia, regurgitation, chronic cough, state of health, and complications. Procedure details such as duration, complications, and technical success were recorded.
Results: Mean size of ZD was 25.6 mm. Mean procedure time was 48 minutes. No major complications (e.g., perforation, mediastinitis) occurred, although one patient suffered from a sinus piriform wound. Follow-up was performed at 3, 6, and 12 months. During follow-up consultations, patients rated improvement in their symptoms as a percentage. At 12 months, 97% of patients reported 100% improvement.
Conclusions: In patients with treatment-naïve ZD, the Clutch Cutter technique is safe, fast, and provides durable symptom remission.
{"title":"Cricopharyngeal myotomy using grasping scissors: Benefits of peroral endoscopic myotomy in symptomatic Zenker's diverticulum.","authors":"Marc Harb, Jean Baptiste Danset, Cynthia Medlij, Olivier Marty, Damien Levoir, Elise Chanteloup, Bernard El Khoury, Christophe Souaid, Yann Le Baleur","doi":"10.1055/a-2703-3219","DOIUrl":"10.1055/a-2703-3219","url":null,"abstract":"<p><strong>Background and study aims: </strong>Multiple therapeutic modalities, including surgery and rigid and flexible endoscopy, have been adopted to manage Zenker's diverticulum (ZD). Relief from symptoms such as dysphagia and regurgitation is the main goal of therapy in symptomatic ZD. This study was the first large cohort that aimed to assess efficacy with time and safety of endoscopic diverticulotomy using the Clutch Cutter.</p><p><strong>Patients and methods: </strong>Cricopharyngeal myotomy was performed in 43 patients at Hospital Saint Joseph de Paris, a tertiary referral center. Symptoms were analyzed before and at 3, 6, and 12 months post-intervention using an extensive questionnaire about dysphagia, odynophagia, regurgitation, chronic cough, state of health, and complications. Procedure details such as duration, complications, and technical success were recorded.</p><p><strong>Results: </strong>Mean size of ZD was 25.6 mm. Mean procedure time was 48 minutes. No major complications (e.g., perforation, mediastinitis) occurred, although one patient suffered from a sinus piriform wound. Follow-up was performed at 3, 6, and 12 months. During follow-up consultations, patients rated improvement in their symptoms as a percentage. At 12 months, 97% of patients reported 100% improvement.</p><p><strong>Conclusions: </strong>In patients with treatment-naïve ZD, the Clutch Cutter technique is safe, fast, and provides durable symptom remission.</p>","PeriodicalId":11671,"journal":{"name":"Endoscopy International Open","volume":"13 ","pages":"a27033219"},"PeriodicalIF":2.3,"publicationDate":"2025-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12550744/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145376290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-10eCollection Date: 2025-01-01DOI: 10.1055/a-2714-3208
Chih-Wen Huang, Yang-Yuan Chen, Hsu-Heng Yen
{"title":"Amber-red color imaging for enhanced visualization and hemostasis during rectal endoscopic submucosal dissection.","authors":"Chih-Wen Huang, Yang-Yuan Chen, Hsu-Heng Yen","doi":"10.1055/a-2714-3208","DOIUrl":"10.1055/a-2714-3208","url":null,"abstract":"","PeriodicalId":11671,"journal":{"name":"Endoscopy International Open","volume":"13 ","pages":"a27143208"},"PeriodicalIF":2.3,"publicationDate":"2025-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12550747/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145372199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-09eCollection Date: 2025-01-01DOI: 10.1055/a-2703-0209
Davide Massimi, Luca Carlini, Yuichi Mori, Luca Di Stefano, Giulio Antonelli, Tommy Rizkala, Marco Spadaccini, Roberto de Sire, Ludovico Alfarone, Chiara Lena, Alessandro D'Aprano, Sravanthi Parasa, Raf Bisschops, Daniel von Renteln, Susanne Margaret O'Reilly, Victor Savevski, Prateek Sharma, Douglas K Rex, Michael Bretthauer, Elena Demomi, Cesare Hassan, Alessandro Repici
Background and study aims: Reporting of colorectal polyp morphology using the Paris classification is often inaccurate. Multimodal large language models (M-LLMs) may support morphological assessment. This study aimed to evaluate the accuracy of an M-LLM (GPT-4o) in classifying colorectal polyp morphology compared with expert and non-expert endoscopists.
Patients and methods: We used the SUN dataset of colonoscopy videos from 100 unique colorectal polyps, each labeled with the validated Paris classification. An M-LLM (GPT-4o) classified five representative frames per lesion. Three expert and three non-expert endoscopists, blinded to one another, performed the same task. The primary outcome was accuracy in differentiating non-polypoid (IIa/IIc) from polypoid (Is/Ip/Isp) lesions. The secondary outcome was accuracy in differentiating sessile (Is) from pedunculated (Ip/Isp) lesions. Given the exploratory design, no multiplicity correction was applied; point estimates are presented with 95% confidence intervals (CIs), and P values are interpreted descriptively.
Results: M-LLM accuracy for differentiating non-polypoid from polypoid lesions was 73% (95% CI 63%-81%), comparable to experts (75%, 65%-83%; P = 0.84) and non-experts (77%, 68%-85%; P = 0.52), with similar sensitivity and specificity. Accuracy for differentiating sessile from pedunculated lesions was 55% (95% CI 42%-67%), lower than experts (76%; P = 0.02) and non-experts (77%; P = 0.01), primarily due to poor specificity (12% vs. experts 82% and non-experts 88%; P < 0.01 for both comparisons).
Conclusions: M-LLMs performed comparably to endoscopists in distinguishing non-polypoid from polypoid lesions but failed to reliably identify pedunculated morphology.
{"title":"Large language model for interpreting the Paris classification of colorectal polyps.","authors":"Davide Massimi, Luca Carlini, Yuichi Mori, Luca Di Stefano, Giulio Antonelli, Tommy Rizkala, Marco Spadaccini, Roberto de Sire, Ludovico Alfarone, Chiara Lena, Alessandro D'Aprano, Sravanthi Parasa, Raf Bisschops, Daniel von Renteln, Susanne Margaret O'Reilly, Victor Savevski, Prateek Sharma, Douglas K Rex, Michael Bretthauer, Elena Demomi, Cesare Hassan, Alessandro Repici","doi":"10.1055/a-2703-0209","DOIUrl":"10.1055/a-2703-0209","url":null,"abstract":"<p><strong>Background and study aims: </strong>Reporting of colorectal polyp morphology using the Paris classification is often inaccurate. Multimodal large language models (M-LLMs) may support morphological assessment. This study aimed to evaluate the accuracy of an M-LLM (GPT-4o) in classifying colorectal polyp morphology compared with expert and non-expert endoscopists.</p><p><strong>Patients and methods: </strong>We used the SUN dataset of colonoscopy videos from 100 unique colorectal polyps, each labeled with the validated Paris classification. An M-LLM (GPT-4o) classified five representative frames per lesion. Three expert and three non-expert endoscopists, blinded to one another, performed the same task. The primary outcome was accuracy in differentiating non-polypoid (IIa/IIc) from polypoid (Is/Ip/Isp) lesions. The secondary outcome was accuracy in differentiating sessile (Is) from pedunculated (Ip/Isp) lesions. Given the exploratory design, no multiplicity correction was applied; point estimates are presented with 95% confidence intervals (CIs), and <i>P</i> values are interpreted descriptively.</p><p><strong>Results: </strong>M-LLM accuracy for differentiating non-polypoid from polypoid lesions was 73% (95% CI 63%-81%), comparable to experts (75%, 65%-83%; <i>P</i> = 0.84) and non-experts (77%, 68%-85%; <i>P</i> = 0.52), with similar sensitivity and specificity. Accuracy for differentiating sessile from pedunculated lesions was 55% (95% CI 42%-67%), lower than experts (76%; <i>P</i> = 0.02) and non-experts (77%; <i>P</i> = 0.01), primarily due to poor specificity (12% vs. experts 82% and non-experts 88%; <i>P</i> < 0.01 for both comparisons).</p><p><strong>Conclusions: </strong>M-LLMs performed comparably to endoscopists in distinguishing non-polypoid from polypoid lesions but failed to reliably identify pedunculated morphology.</p>","PeriodicalId":11671,"journal":{"name":"Endoscopy International Open","volume":"13 ","pages":"a27030209"},"PeriodicalIF":2.3,"publicationDate":"2025-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12511921/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145279179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-09eCollection Date: 2025-01-01DOI: 10.1055/a-2699-9086
Jingjing Yao, Feifei Zhang, Wen Jiao, Hongyuan Cui, Jindong Fu
{"title":"Endoscopic management of a sessile serrated lesion at the appendiceal orifice.","authors":"Jingjing Yao, Feifei Zhang, Wen Jiao, Hongyuan Cui, Jindong Fu","doi":"10.1055/a-2699-9086","DOIUrl":"10.1055/a-2699-9086","url":null,"abstract":"","PeriodicalId":11671,"journal":{"name":"Endoscopy International Open","volume":"13 ","pages":"a26999086"},"PeriodicalIF":2.3,"publicationDate":"2025-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12511915/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145279202","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-09eCollection Date: 2025-01-01DOI: 10.1055/a-2697-7786
ChunChi Lin, Wen-Yih Liang, Jui-Shen Chang, Shih-Ching Chang, Shung-Haur Yang
Background and study aims: The aim of this study was to validation the accuracy of major guidelines and their adopted unfavorable histologic factors for lymph node metastasis (LNM) in pT1 colorectal cancer (CRC). National Comprehensive Cancer Network (NCCN), Japanese Society for Cancer of the Colon and Rectum (JSCCR), European Society for Medical Oncology (ESMO), and French Intergroup Clinical Practice Guidelines (FICPG) were included.
Patients and methods: Retrospectively, 519 cases receiving oncological resection with lymphadenectomy were included. Factors and four pathological parameters--histological differentiation grades (HDG), lymphovascular invasion (LVI), depth of submucosal invasion (DSI)(>1000μm), and tumor budding (TB)--were analyzed for their impact on LNM incidence individually and in combination as defined by the guidelines.
Results: HDG, LVI, TB, and gender (female) are risk factors for LNM in multivariate analysis. All guidelines have significant ability to predict LNM ( P <0.001). NCCN and ESMO have similar performance, in terms of sensitivity (63.8%/68.1%) and specificity (62.7%/69.5%). JSCCR and FICPG had similar performance in terms of good sensitivity (100%/100%) and low specificity (25.6%/25.2%). The JSCCR/FICPG group had higher sensitivity and lower specificity and accuracy than the NCCN/ESMO group.
Conclusions: HDG, LVI, TB, and gender (female) are independent risk factors for LNM of T1 CRC. DSI is an excellent negative predictor, although not an independent risk factor. The NCCN/ESMO guideline has medium sensitivity and requires improvement. The JSCCR/FICPG guideline has perfect sensitivity but low specificity, thus exposing patients to many unnecessary surgeries. There is revision potential for current guideline factors, including those beyond current pathological ones, to improve LNM prediction accuracy.
{"title":"Retrospective accuracy analysis of major guidelines and factors for lymph node metastasis of pT1 colorectal cancer.","authors":"ChunChi Lin, Wen-Yih Liang, Jui-Shen Chang, Shih-Ching Chang, Shung-Haur Yang","doi":"10.1055/a-2697-7786","DOIUrl":"10.1055/a-2697-7786","url":null,"abstract":"<p><strong>Background and study aims: </strong>The aim of this study was to validation the accuracy of major guidelines and their adopted unfavorable histologic factors for lymph node metastasis (LNM) in pT1 colorectal cancer (CRC). National Comprehensive Cancer Network (NCCN), Japanese Society for Cancer of the Colon and Rectum (JSCCR), European Society for Medical Oncology (ESMO), and French Intergroup Clinical Practice Guidelines (FICPG) were included.</p><p><strong>Patients and methods: </strong>Retrospectively, 519 cases receiving oncological resection with lymphadenectomy were included. Factors and four pathological parameters--histological differentiation grades (HDG), lymphovascular invasion (LVI), depth of submucosal invasion (DSI)(>1000μm), and tumor budding (TB)--were analyzed for their impact on LNM incidence individually and in combination as defined by the guidelines.</p><p><strong>Results: </strong>HDG, LVI, TB, and gender (female) are risk factors for LNM in multivariate analysis. All guidelines have significant ability to predict LNM ( <i>P</i> <0.001). NCCN and ESMO have similar performance, in terms of sensitivity (63.8%/68.1%) and specificity (62.7%/69.5%). JSCCR and FICPG had similar performance in terms of good sensitivity (100%/100%) and low specificity (25.6%/25.2%). The JSCCR/FICPG group had higher sensitivity and lower specificity and accuracy than the NCCN/ESMO group.</p><p><strong>Conclusions: </strong>HDG, LVI, TB, and gender (female) are independent risk factors for LNM of T1 CRC. DSI is an excellent negative predictor, although not an independent risk factor. The NCCN/ESMO guideline has medium sensitivity and requires improvement. The JSCCR/FICPG guideline has perfect sensitivity but low specificity, thus exposing patients to many unnecessary surgeries. There is revision potential for current guideline factors, including those beyond current pathological ones, to improve LNM prediction accuracy.</p>","PeriodicalId":11671,"journal":{"name":"Endoscopy International Open","volume":"13 ","pages":"a26977786"},"PeriodicalIF":2.3,"publicationDate":"2025-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12511920/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145279190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}